Novo Nordisk has global metabolic leadership, an oral GLP-1 program, and a stock price below $50 after a retail-driven ...
Eli Lilly's oral GLP-1 candidate, orforglipron, won't earn approval as fast as the company expected. Meanwhile, a notable ...
Eli Lilly and Company (NYSE:LLY) is one of the best stocks to buy and hold for 20 years. On January 20, 2026, Guggenheim reduced its price target on Eli Lilly and Company (NYSE:LLY) from $1,163 to $1, ...
Zacks Investment Research on MSN
Eli Lilly (LLY) stock sinks as market gains: What you should know
In the latest trading session, Eli Lilly (LLY) closed at $1,064.29, marking a -2.12% move from the previous day. This change ...
Having stabilized following a severe downturn last summer, Viking Therapeutics has announced the completion of patient enrollment for a key clinical trial. This technical achievement marks a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results